12 | Adenosine (Adenocard)FDA LinkGeneric
01/2019
-
01/2002 |
10 | cangrelorIBA
01/2020
-
04/2013 |
9 | Adenosine Triphosphate (ATP)IBA
01/2016
-
08/2002 |
8 | Purinergic P1 Receptors (Adenosine Receptor)IBA
06/2012
-
03/2004 |
8 | triphenyltetrazoliumIBA
09/2008
-
09/2002 |
6 | Phosphotransferases (Kinase)IBA
07/2011
-
01/2005 |
5 | Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
01/2019
-
05/2013 |
5 | Purinergic P2Y Receptor AntagonistsIBA
10/2018
-
03/2014 |
5 | WortmanninIBA
10/2013
-
02/2003 |
5 | chelerythrineIBA
10/2013
-
05/2006 |
5 | BradykininIBA
03/2008
-
03/2004 |
4 | Proteins (Proteins, Gene)FDA Link
11/2021
-
03/2004 |
4 | TicagrelorIBA
01/2019
-
10/2013 |
4 | BuffersIBA
01/2019
-
08/2002 |
4 | Opioid Analgesics (Opioids)IBA
01/2016
-
03/2004 |
4 | Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA
05/2012
-
07/2006 |
4 | BAY 60-6583IBA
05/2011
-
09/2007 |
4 | Cyclic GMP-Dependent Protein Kinases (Protein Kinase G)IBA
07/2009
-
08/2004 |
4 | mitochondrial K(ATP) channelIBA
07/2009
-
05/2002 |
4 | Adenosine-5'-(N-ethylcarboxamide) (NECA)IBA
09/2007
-
03/2004 |
4 | 5-hydroxydecanoic acidIBA
04/2007
-
08/2002 |
4 | Acetylcholine (Acetylcholine Chloride)FDA Link
04/2005
-
08/2002 |
3 | cariporideIBA
03/2014
-
10/2002 |
3 | Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2012
-
07/2006 |
3 | 1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA
03/2011
-
04/2007 |
3 | SB 216763IBA
12/2010
-
07/2006 |
3 | NG-Nitroarginine Methyl Ester (L-NAME)IBA
12/2010
-
01/2006 |
3 | Oxygen (Dioxygen)IBA
09/2008
-
04/2007 |
3 | Mitochondrial Permeability Transition PoreIBA
09/2008
-
07/2006 |
3 | Free Radical ScavengersIBA
07/2008
-
08/2002 |
3 | Reactive Oxygen Species (Oxygen Radicals)IBA
04/2007
-
08/2002 |
3 | OxadiazolesIBA
07/2006
-
08/2004 |
3 | Ethanol (Ethyl Alcohol)IBA
04/2004
-
05/2002 |
2 | Phosphates (Orthophosphate)IBA
11/2021
-
01/2019 |
2 | Crystalloid SolutionsIBA
01/2019
-
12/2003 |
2 | Purinergic P1 Receptor AntagonistsIBA
01/2019
-
06/2012 |
2 | Clopidogrel (Plavix)FDA Link
01/2019
-
05/2013 |
2 | belnacasanIBA
10/2018
-
11/2017 |
2 | interleukin-1beta-converting enzyme inhibitorIBA
10/2018
-
11/2017 |
2 | Peptides (Polypeptides)IBA
11/2017
-
12/2003 |
2 | Opioid Receptors (Opioid Receptor)IBA
01/2016
-
06/2012 |
2 | LigandsIBA
01/2016
-
07/2008 |
2 | Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA
10/2013
-
01/2005 |
2 | FluorocarbonsIBA
06/2012
-
02/2007 |
2 | Theophylline (Theon)FDA LinkGeneric
06/2012
-
01/2005 |
2 | Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
05/2011
-
03/2006 |
2 | Soluble Guanylyl CyclaseIBA
12/2010
-
07/2006 |
2 | N- (4- cyanophenyl)- 2- (4- (2,3,6,7- tetrahydro- 2,6- dioxo- 1,3- dipropyl- 1H- purin- 8- yl)- phenoxy)acetamideIBA
09/2008
-
05/2006 |
2 | Protein Kinase CIBA
09/2008
-
04/2007 |
2 | Glycine (Aminoacetic Acid)FDA LinkGeneric
07/2008
-
04/2007 |
2 | AutacoidsIBA
03/2008
-
10/2003 |
2 | Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA
04/2007
-
03/2004 |
2 | Nitric Oxide (Nitrogen Monoxide)FDA Link
05/2006
-
09/2004 |
2 | Guanylate Cyclase (Guanylyl Cyclase)IBA
01/2005
-
08/2004 |
2 | Potassium Channels (Potassium Channel)IBA
12/2003
-
08/2002 |
2 | 4- (7- ((2- 3- chloro- 2- thienyl)- 1- methyl- propylamino)- 3H- imidazo(4,5- b)pyridyl- 3- yl)cyclopentane carboxamideIBA
11/2003
-
10/2002 |
2 | Diazoxide (Hyperstat)FDA Link
08/2002
-
05/2002 |
1 | Purinergic P2X7 ReceptorsIBA
11/2021 |
1 | Toll-Like Receptors (Toll-Like Receptor)IBA
11/2021 |
1 | Pyruvic Acid (Pyruvate)IBA
11/2021 |
1 | MicroRNAs (MicroRNA)IBA
11/2021 |
1 | Oxidoreductases (Dehydrogenase)IBA
11/2021 |
1 | Caspase 1 (ICE Protease)IBA
11/2021 |
1 | EnzymesIBA
11/2021 |
1 | Adrenergic Receptors (Adrenergic Receptor)IBA
11/2021 |
1 | InterleukinsIBA
11/2021 |
1 | Toll-Like Receptor AgonistsIBA
11/2021 |
1 | InflammasomesIBA
11/2021 |
1 | Platelet Activating FactorIBA
01/2019 |
1 | Protect-ItIBA
01/2019 |
1 | CytokinesIBA
01/2019 |
1 | ProdrugsIBA
10/2018 |
1 | Pharmaceutical PreparationsIBA
10/2018 |
1 | Coloring Agents (Dyes)IBA
11/2017 |
1 | Cannabinoid Receptor AgonistsIBA
01/2016 |
1 | CannabinoidsIBA
01/2016 |
1 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2016 |
1 | Deoxyribonucleases (DNase)FDA Link
03/2015 |